questionsmedicales.fr
Tissus
Tissu conjonctif
Os et tissu osseux
Os spongieux
Os spongieux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Ostéoporose
Imagerie médicale
Fractures
Douleur osseuse
Densitométrie osseuse
Ostéoporose
Douleur osseuse
Fractures
Symptômes
5
Ostéoporose
Douleur osseuse
Ostéomalacie
Douleur osseuse
Traitements
5
Ostéoporose
Bisphosphonates
Fractures
Chirurgie orthopédique
Bisphosphonates
Raloxifène
Physiothérapie
Réhabilitation
Complications
5
Ostéomalacie
Douleur osseuse
Infection osseuse
Douleur
Médicaments
Santé osseuse
Facteurs de risque
5
Ostéoporose
Facteurs de risque
Mode de vie
Santé osseuse
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Os spongieux : Questions médicales les plus fréquentes",
"headline": "Os spongieux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Os spongieux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-08",
"dateModified": "2025-05-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Os spongieux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Os et tissu osseux",
"url": "https://questionsmedicales.fr/mesh/D001842",
"about": {
"@type": "MedicalCondition",
"name": "Os et tissu osseux",
"code": {
"@type": "MedicalCode",
"code": "D001842",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A10.165.265"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Os spongieux",
"alternateName": "Cancellous Bone",
"code": {
"@type": "MedicalCode",
"code": "D000071556",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad Salem",
"url": "https://questionsmedicales.fr/author/Mohammad%20Salem",
"affiliation": {
"@type": "Organization",
"name": "Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada."
}
},
{
"@type": "Person",
"name": "Lindsey Westover",
"url": "https://questionsmedicales.fr/author/Lindsey%20Westover",
"affiliation": {
"@type": "Organization",
"name": "Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada."
}
},
{
"@type": "Person",
"name": "Samer Adeeb",
"url": "https://questionsmedicales.fr/author/Samer%20Adeeb",
"affiliation": {
"@type": "Organization",
"name": "Department of Civil and Environmental Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada."
}
},
{
"@type": "Person",
"name": "Kajsa Duke",
"url": "https://questionsmedicales.fr/author/Kajsa%20Duke",
"affiliation": {
"@type": "Organization",
"name": "Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada."
}
},
{
"@type": "Person",
"name": "Bin Wu",
"url": "https://questionsmedicales.fr/author/Bin%20Wu",
"affiliation": {
"@type": "Organization",
"name": "College of Mechanical and Electronic Engineering, Nanjing Forestry University, Nanjing 210037, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Phosphate intake, hyperphosphatemia, and kidney function.",
"datePublished": "2022-05-05",
"url": "https://questionsmedicales.fr/article/35511366",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00424-022-02691-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Non-occlusive Mesenteric Ischemia with Significant Hyperphosphatemia.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35908963",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2169/internalmedicine.0074-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperphosphatemia during nutrition recovery in patients with severe anorexia nervosa.",
"datePublished": "2022-11-24",
"url": "https://questionsmedicales.fr/article/36437197",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.endien.2021.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Refractoriness of Hyperkalemia and Hyperphosphatemia in Dialysis-Dependent AKI Associated with COVID-19.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/36176653",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34067/KID.0001632022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37241191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina59050959"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tissus",
"item": "https://questionsmedicales.fr/mesh/D014024"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tissu conjonctif",
"item": "https://questionsmedicales.fr/mesh/D003238"
},
{
"@type": "ListItem",
"position": 4,
"name": "Os et tissu osseux",
"item": "https://questionsmedicales.fr/mesh/D001842"
},
{
"@type": "ListItem",
"position": 5,
"name": "Os spongieux",
"item": "https://questionsmedicales.fr/mesh/D000071556"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Os spongieux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Os spongieux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Os spongieux",
"description": "Comment diagnostiquer une fragilité osseuse ?\nQuels tests sanguins sont utiles ?\nQuels signes indiquent une maladie osseuse ?\nQuand faire une densitométrie osseuse ?\nQuels symptômes nécessitent une évaluation osseuse ?",
"url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Hyperphosphatemia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Os spongieux",
"description": "Quels sont les symptômes d'une fracture osseuse ?\nComment reconnaître l'ostéoporose ?\nQuels signes de faiblesse osseuse ?\nY a-t-il des symptômes associés à l'ostéomalacie ?\nQuels symptômes d'une infection osseuse ?",
"url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Hyperphosphatemia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Os spongieux",
"description": "Comment prévenir l'ostéoporose ?\nQuel rôle de l'exercice pour les os ?\nPourquoi éviter le tabac pour les os ?\nComment la vitamine D aide-t-elle les os ?\nQuels aliments sont bons pour les os ?",
"url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Hyperphosphatemia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Os spongieux",
"description": "Quels traitements pour l'ostéoporose ?\nComment traiter une fracture osseuse ?\nQuels médicaments renforcent les os ?\nQuel rôle de la physiothérapie ?\nComment la nutrition aide-t-elle les os ?",
"url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Hyperphosphatemia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Os spongieux",
"description": "Quelles complications des fractures ?\nQuels risques d'ostéoporose non traitée ?\nComment l'ostéomalacie complique-t-elle la santé ?\nQuelles complications des infections osseuses ?\nQuels effets des médicaments sur les os ?",
"url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Hyperphosphatemia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Os spongieux",
"description": "Quels facteurs augmentent le risque d'ostéoporose ?\nComment l'alimentation influence-t-elle les os ?\nQuel impact du mode de vie sur la santé osseuse ?\nLes antécédents familiaux influencent-ils les os ?\nQuel rôle du sexe dans la santé osseuse ?",
"url": "https://questionsmedicales.fr/mesh/D000071556?mesh_terms=Hyperphosphatemia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une fragilité osseuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des examens d'imagerie comme la radiographie ou l'IRM."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de calcium, vitamine D et marqueurs de remodelage osseux aident au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une maladie osseuse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs osseuses, fractures fréquentes et perte de hauteur peuvent indiquer une maladie."
}
},
{
"@type": "Question",
"name": "Quand faire une densitométrie osseuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est recommandée pour les personnes à risque d'ostéoporose, généralement après 50 ans."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une évaluation osseuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs persistantes ou des fractures sans traumatisme doivent être évaluées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une fracture osseuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleur intense, gonflement et incapacité à utiliser le membre affecté sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître l'ostéoporose ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ostéoporose est souvent asymptomatique jusqu'à une fracture, mais peut causer des douleurs."
}
},
{
"@type": "Question",
"name": "Quels signes de faiblesse osseuse ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Perte de hauteur, courbure de la colonne vertébrale et fractures fréquentes sont des signes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à l'ostéomalacie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs osseuses, faiblesse musculaire et déformations osseuses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection osseuse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur localisée et rougeur autour de l'os peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'ostéoporose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et l'arrêt du tabac sont essentiels."
}
},
{
"@type": "Question",
"name": "Quel rôle de l'exercice pour les os ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice renforce les os et améliore l'équilibre, réduisant le risque de chutes."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter le tabac pour les os ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme réduit la densité osseuse et augmente le risque de fractures."
}
},
{
"@type": "Question",
"name": "Comment la vitamine D aide-t-elle les os ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vitamine D favorise l'absorption du calcium, essentielle pour la santé osseuse."
}
},
{
"@type": "Question",
"name": "Quels aliments sont bons pour les os ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les produits laitiers, les légumes verts et les poissons gras sont bénéfiques pour les os."
}
},
{
"@type": "Question",
"name": "Quels traitements pour l'ostéoporose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bisphosphonates, la vitamine D et l'exercice sont des traitements courants."
}
},
{
"@type": "Question",
"name": "Comment traiter une fracture osseuse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure immobilisation, chirurgie ou réhabilitation selon la gravité."
}
},
{
"@type": "Question",
"name": "Quels médicaments renforcent les os ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments comme le raloxifène et les bisphosphonates aident à renforcer les os."
}
},
{
"@type": "Question",
"name": "Quel rôle de la physiothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La physiothérapie aide à renforcer les muscles et améliorer la mobilité après une fracture."
}
},
{
"@type": "Question",
"name": "Comment la nutrition aide-t-elle les os ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en calcium et vitamine D est essentielle pour la santé osseuse."
}
},
{
"@type": "Question",
"name": "Quelles complications des fractures ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'infection, la non-union osseuse et la douleur chronique."
}
},
{
"@type": "Question",
"name": "Quels risques d'ostéoporose non traitée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ostéoporose non traitée augmente le risque de fractures graves et de déformations."
}
},
{
"@type": "Question",
"name": "Comment l'ostéomalacie complique-t-elle la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des déformations osseuses et des douleurs chroniques si non traitée."
}
},
{
"@type": "Question",
"name": "Quelles complications des infections osseuses ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections osseuses peuvent causer des douleurs persistantes et des dommages osseux."
}
},
{
"@type": "Question",
"name": "Quels effets des médicaments sur les os ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent entraîner une perte osseuse ou des effets secondaires indésirables."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'ostéoporose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le sexe féminin, l'hérédité et un mode de vie sédentaire augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle les os ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation pauvre en calcium et vitamine D augmente le risque de maladies osseuses."
}
},
{
"@type": "Question",
"name": "Quel impact du mode de vie sur la santé osseuse ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et le tabagisme nuisent à la santé osseuse."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils les os ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'ostéoporose augmentent le risque personnel."
}
},
{
"@type": "Question",
"name": "Quel rôle du sexe dans la santé osseuse ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes, surtout après la ménopause, sont plus à risque d'ostéoporose que les hommes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/05/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Civil and Environmental Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
College of Mechanical and Electronic Engineering, Nanjing Forestry University, Nanjing 210037, China.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Orthodontics, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing 210029, China.
Jiangsu Province Key Laboratory of Oral Diseases, Nanjing 210029, China.
Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing 210029, China.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
College of Mechanical and Electronic Engineering, Nanjing Forestry University, Nanjing 210037, China.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Institute of General Mechanics, RWTH-Aachen University, 52062 Aachen, Germany.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Orthodontics, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing 210029, China.
Jiangsu Province Key Laboratory of Oral Diseases, Nanjing 210029, China.
Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing 210029, China.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
College of Mechanical and Electronic Engineering, Nanjing Forestry University, Nanjing 210037, China.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Center for Frontier Medical Engineering, Chiba University, Chiba, Japan.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Center for Frontier Medical Engineering, Chiba University, Chiba, Japan.
Med-Tech Link Center, Chiba University, Chiba, Japan.
Department of Medical Engineering, Graduate School of Science and Engineering, Chiba University, Chiba, Japan.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Center for Frontier Medical Engineering, Chiba University, Chiba, Japan.
Med-Tech Link Center, Chiba University, Chiba, Japan.
Department of Medical Engineering, Graduate School of Science and Engineering, Chiba University, Chiba, Japan.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Physics, Rhodes College, Memphis, Tennessee 38112, USA.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Physics, Rhodes College, Memphis, Tennessee 38112, USA.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Bharti School of Engineering, Laurentian University, Sudbury, Ontario, Canada.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Mechanical and Materials Engineering, Queen's University, Kingston, Ontario, Canada.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Bharti School of Engineering, Laurentian University, Sudbury, Ontario, Canada. Electronic address: blievers@laurentian.ca.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopaedic Surgery, Shimane University Faculty of Medicine, Shimane, Japan. Electronic address: imades@med.shimane-u.ac.jp.
Publications dans "Os spongieux" :
2 publications dans cette catégorie
Affiliations :
Department of Manufacturing Technology, Shimane Institute for Industrial Technology, Shimane, Japan.
Publications dans "Os spongieux" :
Phosphate is essential in living organisms and its blood levels are regulated by a complex network involving the kidneys, intestine, parathyroid glands, and the skeleton. The crosstalk between these o...
An 86-year-old Japanese woman was referred to our hospital due to the sudden onset of abdominal pain. Abdominal contrast-enhanced computed tomography (CT) revealed no signs of ischemic bowel; however,...
Anorexia nervosa (AN) is a disorder associated with many medical complications. Regarding phosphorus metabolism, the only recognized alteration is hypophosphatemia associated with refeeding syndrome. ...
We carried out a retrospective study of patients with AN hospitalized for severe decompensation of the disease....
Eleven patients were included, all women, with a median age of 23 years [20-46] and a body mass index at admission of 12.2 kg/m...
Late hyperphosphatemia during nutrition therapy in severely undernourished AN patients affects more than 80% of cases. Body weight gain throughout nutrition therapy is a predictor of increased P level...
Persistent hyperkalemia (hyperK) and hyperphosphatemia (hyperP) despite renal replacement therapy (RRT) was anecdotally reported in COVID-19 and acute kidney injury (AKI) requiring RRT (CoV-AKI-RRT). ...
We identified patients with CoV-AKI-RRT treated with sustained low-efficiency dialysis (SLED) for ≥2 days in March-April 2020. As pre-COVID-19 control, we included patients with AKI treated with SLED ...
Along the duration of SLED, the incidence of hyperK was greater in CoV-AKI-RRT (...
Refractory hyperK and hyperP were more frequent in CoV-AKI-RRT compared with the pre-COVID-19 era. Because of the correlation of sK and sP with higher LDH and sP with shorter SLED runs, intracellular ...
Hyperphosphatemia is a secondary disorder of chronic kidney disease that causes vascular calcifications and bone-mineral disorders. As per the US Centers for Disease Control and Prevention, renal dama...
Vascular calcification is quite common in patients with end-stage chronic kidney disease and is a major trigger for cardiovascular complications in these patients. These complications significantly im...
Nonrespiratory manifestations of COVID-19 include endocrine disorders, among which are calcium-magnesium-phosphate homeostasis abnormalities, which seem to influence the disease severity and patient o...
The study was conducted between April 2020 and May 2021 at Central Clinical Hospital in Warsaw, Poland. A total of 146 patients who had tested concentration of at least one of the studied elements, es...
We found that hypermagnesemia was common and associated with a 1.5-fold increased risk of death in the whole cohort. Hyperphosphatemia also increased the risk of death, exactly 2.4-fold. Furthermore, ...
Hypermagnesemia, hyperphosphatemia, and hypovitaminosis D but not hypocalcemia influence the mortality of patients with COVID-19. These parameters should be monitored routinely in this group of patien...
Herein, we compared the association intensity of estimated glomerular filtration rate (eGFR) equations using creatinine (Cr) or cystatin C (CysC) with hyperphosphatemia and secondary hyperparathyroidi...
Hyperphosphatemia occurs frequently in end-stage renal disease patients on hemodialysis and is associated with increased mortality. Hyperphosphatemia contributes to vascular calcification in these pat...
We conducted a cross-sectional study in hypertensive hemodialysis patients. We obtained pre-hemodialysis measurements of total peripheral resistance index (TPRI, non-invasive cardiac output monitor) a...
There were 54 patients analyzed. Mean pre-HD supine and seated systolic and diastolic BP were 164 (27), 158 (21), 91.5 (17), and 86.1 (16) mmHg. Mean serum phosphate was 5.89 (1.8) mg/dL. There were s...
Serum phosphate concentration is independently associated with higher pre-HD BP, vasoconstriction, and markers of endothelial cell dysfunction. These findings demonstrate an additional negative impact...
The study was part of a registered clinical trial, NCT01862497 (May 24, 2013)....
Patients with chronic kidney disease (CKD), hyperkalemia (serum potassium [sK...
A post hoc pooled analysis of individual-level data from the AMETHYST-DN, OPAL-HK, and TOURMALINE trials of patiromer....
Patients with CKD and hyperkalemia....
Patients treated with patiromer (8.4-33.6 g/day)....
Mean changes from baseline in sP, sK...
Descriptive statistics to summarize pooled data on the study outcomes from the 3 studies....
We included 578 patients in the analysis. Of these participants, 86 patients (14.9%) had baseline hyperphosphatemia of whom 75.6% (65 of 86) had CKD stage 4/5 and 31.1% (153 of 492) with sP≤4.5mg/dL h...
These were post hoc analyses, no placebo comparison was performed due to the design of the original studies, and the follow-up period was limited to 4 weeks....
Reductions in sP and sK...